Sales Nexus CRM

Stonegate Capital Partners Updates Coverage on Valens Semiconductor, Highlighting 1Q26 Results and 2H Acceleration Thesis

By FisherVista
Valens Semiconductor reported 1Q26 revenue of $16.9M and gross margin above guidance, while reiterating FY26 guidance, with Stonegate Capital Partners emphasizing a stronger second half driven by CIB growth and product-cycle execution.

Found this article helpful?

Share it with your network and spread the knowledge!

Stonegate Capital Partners Updates Coverage on Valens Semiconductor, Highlighting 1Q26 Results and 2H Acceleration Thesis

Stonegate Capital Partners has updated its coverage on Valens Semiconductor Ltd. (NYSE:VLN) following the company's first-quarter 2026 earnings report. Valens Semiconductor reported 1Q26 revenue of $16.9 million, compared with $19.4 million in the fourth quarter of 2025 and $16.8 million in the first quarter of 2025. The GAAP gross margin came in at 62.2%, above the company's guidance range of 57.0% to 59.0%. Adjusted EBITDA loss was $(5.5) million, better than the guided range of $(7.9) million to $(7.5) million. While revenue stepped down sequentially after a stronger fourth quarter, results were modestly ahead of expectations, and management reiterated its full-year 2026 revenue guidance of $75.0 million to $77.0 million.

Stonegate Capital Partners views 2026 as a year of measured recovery and product-cycle execution for Valens Semiconductor. Near-term growth is expected to build through the year as the Company's Core Infrastructure Business (CIB) returns to sequential growth, automotive remains steady, and the A-PHY ecosystem development continues. Management noted that broader supply-chain conditions remain an area to monitor but stated that it does not see risk to meeting its full-year targets. The key thesis variable for Valens Semiconductor is a meaningful acceleration in the second half of 2026, driven by CIB sequential growth, ProAV momentum, and design wins and design-ins converting into customer launches in the third and fourth quarters of 2026.

In the automotive segment, revenue grew to $5.9 million, while the VA7000 platform is gaining traction in industrial machine vision and medical endoscopy, expanding the addressable opportunity beyond core A-PHY automotive applications. However, revenue contribution from these adjacent markets is likely several quarters out, providing longer-duration optionality for the company. The full announcement, including downloadable images and bios, is available here.

Valens Semiconductor's execution remains ahead of plan despite a slower first-half setup. The company delivered first-quarter revenue of $16.9 million, gross margin of 62.2% above guidance, and adjusted EBITDA loss of $(5.5) million, better than guided, while reiterating full-year revenue guidance of $75.0 million to $77.0 million. The implications for investors and the industry are significant: Valens Semiconductor is navigating supply-chain challenges and positioning itself for a stronger second half, with potential catalysts from ProAV momentum and new product launches. The company's ability to maintain guidance amid a challenging environment underscores its operational discipline and the underlying demand for its semiconductor solutions in automotive and industrial applications.

FisherVista

FisherVista

@fishervista